Year: 2021
Type: review
Abstract: hotspot mutations are missense mutations. Mutant p53 proteins, encoded by these hotspot mutations, lose canonical wild-type p53 functions and gain functions that promote cancer development, including promoting cancer cell proliferation, migration, invasion, initiation, metabolic reprogramming, angiogenesis, and conferring drug resistance to cancer cells. Among these hotspot mutations, p53-R175H has the highest occurrence. Although losing the transactivating function of the wild-type p53 and prone to aggregation, p53-R175H gains oncogenic functions by interacting with many proteins. In this review, we summarize the gain of functions of p53-R175H in different cancer types, the interacting proteins of p53-R175H, and the downstream signaling pathways affected by p53-R175H to depict a comprehensive role of p53-R175H in cancer development. We also summarize treatments that target p53-R175H, including reactivating p53-R175H with small molecules that can bind to p53-R175H and alter it into a wild-type-like structure, promoting the degradation of p53-R175H by targeting heat-shock proteins that maintain the stability of p53-R175H, and developing immunotherapies that target the p53-R175H-HLA complex presented by tumor cells.
Source: Cancers
Authors: Yen-Ting Chiang(Writing – original draft), Yi-Chung Chien(Software), Yu-Heng Lin(Software), Hui-Hsuan Wu(Software), Dung-Fang Lee(Conceptualization, Funding acquisition, Project administration, Supervision, Writing – review & editing), Yung-Luen Yu(Conceptualization, Funding acquisition, Project administration, Supervision, Writing – review & editing)
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $2,376
Funders: Cancer Prevention and Research Institute of Texas, China Medical University Hospital, Ministry of Education, India, Ministry of Science and Technology, Taiwan, China Medical University, China Medical University, Taiwan, National Institutes of Health, National Cancer Institute, Division of Materials Research
Awards: G1439753050, G2123449318, G2205640134, G3429950952, The Roles of Trim21 Ubiquitin Ligase in Glioblastoma (II) -Dissecting the Epigenetic Regulation of Tumor Immunology, G5053496065, G5510651702, G5790954272, G5825252661, G631617849, Recruitment of First-Time, Tenure-Track Faculty Members, G6841231352, G7179392879, G7659253194, G7661794451, G775445806, G825235845, G889902462, Dissecting and Targeting RB1-Mutant Osteosarcoma
OpenAlex ID: W3195582737
